Succinylacetone as Primary Marker to Detect Tyrosinemia Type I in Newborns and its Measurement by Newborn Screening Programs

Lignende værker

• Newborn Screening for Tyrosinemia Type I: Further Evidence that Succinylacetone Determination on Blood Spot Is Essential
  af: la Marca, Giancarlo, et al.
  Udgivet: (2011)
• Newborn screening for Tyrosinemia type 1 using succinylacetone – a systematic review of test accuracy
  af: Stinton, Chris, et al.
  Udgivet: (2017)
• The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening
  af: Priestley, Jessica R. C., et al.
  Udgivet: (2020)
• Evaluation of the Performance of Newborn Screening for Tyrosinemia Type 1 in The Netherlands: Suggestions for Improvements Using Additional Biomarkers in Addition to Succinylacetone
  af: Marelle J. Bouva, et al.
  Udgivet: (2025-05-01)
• The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-five Year Experience Assuring Newborn Screening Laboratory Quality
  af: De Jesús, Víctor R., et al.
  Udgivet: (2015)